Insulin glargine biosimilar (Valin Technologies)
甘精胰岛素生物类似药 (Valin Technologies)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameInsulin glargine biosimilar (Valin Technologies)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesValin Technologies
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A